An inventory of European data sources for the long-term safety evaluation of methylphenidate
Authors:
- Macey L. MurrayMMMacey L. Murray
- Tobias BanaschewskiTBTobias Banaschewski
- Antje C. NeubertANAntje C. Neubert
- Suzanne McCarthySMSuzanne McCarthy
- Jan K. BuitelaarJBJan K. Buitelaar
- David CoghillDCDavid Coghill
- Ralf W. DittmannRDRalf W. Dittmann
- Kerstin KonradKKKerstin Konrad
- Pietro PaneiPPPietro Panei
- Eric RosenthalEREric Rosenthal
- Edmund J. Sonuga-BarkeESEdmund J. Sonuga-Barke
Open Access
- 19 March 2013
- journal article
- research article
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 22 (10) , 605-618
Abstract
To compile an inventory of European healthcare databases with potential to study long-term effects of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder (ADHD). Potential databases were identified through expert opinion, the website of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, and literature search. An online survey was conducted among database providers/coordinators to ascertain the databases’ appropriateness for inclusion into the inventory. It included questions about database characteristics, sample size, availability of information on drug exposure, clinical data and accessibility. Forty-two databases from 11 countries were identified and their coordinators invited to participate; responses were obtained for 22 (52.4 %) databases of which 15 record ADHD diagnoses. Eleven had sufficient data on ADHD diagnosis, drug exposure, and at least one type of outcome information (symptoms/clinical events, weight, height, blood pressure, heart rate) to assess MPH safety. These were Aarhus University Prescription Database, Danish National Birth Cohort (Denmark); German Health Interview and Examination Survey for Children and Adolescents; Health Search Database Thales, Italian ADHD Register, Lombardy Region ADHD Database (Italy); Avon Longitudinal Study of Parents and Children, General Practice Research Database, The Health Improvement Network, QResearch (UK) and IMS Disease Analyzer (UK, Germany, France). Of the 20 databases with no responses, information on seven from publications and/or websites was obtained; Pedianet and the Integrated Primary Care Information database were considered suitable. Many European healthcare databases can be used for multinational long-term safety studies of MPH. Methodological research is underway to investigate the feasibility of their pooling and analysis.Keywords
This publication has 32 references indexed in Scilit:
- The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary careBMC Pediatrics, 2012
- Maternal Thyroid Autoimmunity During Pregnancy and the Risk of Attention Deficit/Hyperactivity Problems in Children: The Generation R StudyThyroid®, 2012
- Existing data sources for clinical epidemiology: Aarhus University Prescription DatabaseClinical Epidemiology, 2010
- European guidelines on managing adverse effects of medication for ADHDEuropean Child & Adolescent Psychiatry, 2010
- The Generation R Study: design and cohort update 2010European Journal of Epidemiology, 2010
- Assessment of Pediatric asthma drug use in three European countries; a TEDDY studyEuropean Journal of Pediatrics, 2010
- Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug TreatmentDrug Safety, 2009
- Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adultsThe British Journal of Psychiatry, 2009
- How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS)European Child & Adolescent Psychiatry, 2008
- The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS-StudyBMC Public Health, 2008